CLINICAL_TRIALS
trial_result
· 2024-06-18
Clinical Trial Update: A Study of Galcanezumab (LY2951742) in Adult Participants With Episodic Migraine [Phase 4]
Summary
Phase 4 study of galcanezumab in adults with episodic migraine has completed, and results were posted on 2024-06-18.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Migraine, Episodic Migraine | Phase 4 | Status: COMPLETED | Results posted: 2024-06-18